SCHEMBL6008682

SCHEMBL6008682

CC(C)c1cc(C(C)C)c(S(=O)(=O)NC(CCN2CCC(Cc3ccccc3)CC2)c2ccccc2)c(C(C)C)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.46
SLC6A2 P23975 2/20 0.45
SLC6A3 Q01959 2/20 0.45
CCR5 P51681 1/20 0.45
PLAU P00749 4/20 0.45
PLAT P00750 2/20 0.45
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
PRMT6 Q96LA8 2/20 0.44
CARM1 Q86X55 1/20 0.44
CCR3 P51677 1/20 0.42
F10 P00742 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5448769 0.83 SLC6A2 (0.53) OPRM1SLC6A2SLC6A3CCR5GRIN2D
SCHEMBL6008053 0.82 SLC6A2 (0.54) OPRM1SLC6A2SLC6A3CCR5GRIN2D
SCHEMBL6007229 0.81 KDM4E (0.56) OPRM1SLC6A2SLC6A3CCR5GRIN2D
SCHEMBL6007222 0.78 ALDH1A1 (0.56) OPRM1SLC6A2SLC6A3CCR5GRIN2D
SCHEMBL5759449 0.77 CCR5 (0.44) SLC6A2SLC6A3CCR5PLAUPLAT
SCHEMBL31212415 0.77 MEN1 (0.55)
SCHEMBL6008830 0.76 PRMT6 (0.63) SLC6A2SLC6A3GRIN2DGRIN3BADRA1D
SCHEMBL6009357 0.76 TMEM97 (0.47) SLC6A2SLC6A3GRIN2DGRIN3BADRA1D
SCHEMBL6007256 0.75 MEN1 (0.56) SLC6A2SLC6A3CCR5GRIN2AGRIN2B
SCHEMBL5759445 0.75 CCR5 (0.47) OPRM1SLC6A2SLC6A3CCR5CCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US claimed
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-06-05 US claimed
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US disclosed
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SIGMAR1, TAAR1, OPRL1 OPRM1 7/4885SLC6A2 20/4885SLC6A3 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.